Stahl Maria D
Insider CIK 1494425 · IDIX SVP & General Counsel · TTPH See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TTPH TETRAPHASE PHARMACEUTICALS | D To issuer deriv | 2020-07-28 | 2020-07-29 | 6,156 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | D To issuer deriv | 2020-07-28 | 2020-07-29 | 1,382 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | D To issuer deriv | 2020-07-28 | 2020-07-29 | 934 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | D To issuer deriv | 2020-07-28 | 2020-07-29 | 640 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | D To issuer deriv | 2020-07-28 | 2020-07-29 | 1,800 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | D To issuer deriv | 2020-07-28 | 2020-07-29 | 675 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | D To issuer deriv | 2020-07-28 | 2020-07-29 | 335 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | D To issuer deriv | 2020-07-28 | 2020-07-29 | 2,850 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | U Tender | 2020-07-28 | 2020-07-29 | 250 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2019-08-01 | 2019-08-02 | 57,000 | — | $0 | 57,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2019-08-01 | 2019-08-02 | 18,000 | — | $0 | 18,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award | 2019-04-02 | 2019-08-02 | 13,913 | — | $0 | 37,611 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2019-01-17 | 2019-01-18 | 140,000 | — | $0 | 140,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2019-01-17 | 2019-01-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award | 2019-01-06 | 2019-01-18 | 18,698 | — | $0 | 23,698 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2018-04-02 | 2018-04-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2018-01-17 | 2018-01-19 | 115,000 | — | $0 | 115,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2018-01-17 | 2018-01-19 | 32,000 | — | $0 | 32,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2017-01-31 | 2017-02-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2017-01-30 | 2017-02-01 | 115,000 | — | $0 | 115,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award | 2016-05-17 | 2016-05-19 | 2,500 | $3.75 | $9.4K | 5,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award | 2016-05-17 | 2016-05-19 | 2,500 | $3.89 | $9.7K | 2,500 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2016-01-06 | 2016-01-08 | 80,000 | — | $0 | 80,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2016-01-06 | 2016-01-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2015-03-04 | 2015-03-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 100,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 100,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 80,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 150,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 100,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2014-02-10 | 2014-02-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2013-02-20 | 2013-02-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2012-02-29 | 2012-03-02 | 100,000 | — | $0 | 100,000 | SEC↗ |